virus covid-19 Coronavirus

Remdesivir: 'Very potent inhibitor' of SARS-CoV-2?

Reading now: 694
www.medicalnewstoday.com

Experimental Ebola drug remdesivir could stop SARS-CoV-2 from replicating by acting on a key enzyme, according to a new study from the University of Alberta.

Last month, the World Health Organization (WHO) announced the launch of a multinational trial, testing the four most promising therapeutic avenues for COVID-19.

One of these avenues is remdesivir, a drug that research scientists initially developed for the treatment of Ebola, but which has recently shown some promise in fighting coronaviruses.

Following on from this evidence, and reports that the drug may have helped some patients seeking treatment for COVID-19 to recover, scientists have been studying remdesivir’s effects on SARS-CoV-2.

Read more on medicalnewstoday.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA